# TWIRLA
> **NDA204017** · New Drug Application · Sponsor: AGILE · Approved 2020-02-14
## Drug
- **FDA Application Number:** NDA204017
- **Application type:** New Drug Application
- **Brand name:** TWIRLA
- **Generic name:** LEVONORGESTREL/ETHINYL ESTRADIOL
- **Active ingredients:** ETHINYL ESTRADIOL; LEVONORGESTREL
- **Dosage form:** SYSTEM
- **Route:** TRANSDERMAL
- **Marketing status:** Prescription
- **Sponsor:** AGILE
- **Manufacturer:** Agile Therapeutics, Inc.
- **First approval:** 2020-02-14
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204017)
---
*AI Analytics · CC0 1.0*